Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - Predictive Oncology Inc.exh_312.htm
EX-31.1 - EXHIBIT 31.1 - Predictive Oncology Inc.exh_311.htm
EX-23.1 - EXHIBIT 23.1 - Predictive Oncology Inc.exh_231.htm
10-K - FORM 10-K - Predictive Oncology Inc.f10k_040218p.htm

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Skyline Medical Inc. (the "Company") for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Carl Schwartz, Chief Executive Officer, and I, Bob Myers, Chief Financial Officer, of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to our knowledge:

  

(1)  The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

 

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 2, 2018

 

/s/ Carl Schwartz   

Carl Schwartz

Chief Executive Officer

(Principal Executive Officer)

 

/s/ Bob Myers   

Bob Myers

Chief Financial Officer

(Principal Financial Officer)